pay to delay
How 'Pay-for-Delay' Keeps Brand-Name Drug Prices High While Blocking Generics
The practice is no closed-door secret, and finds brand-name drug manufacturers offering financial incentives--one might call them bribes--to generic manufacturers so as to prevent generic drugs from entering the market.
Advertisement
Advertisement
Advertisement